PATENT CLAIM ANALYSIS

Application Number: 16279015
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-08
Patent Classification: ["514", "574000"]

Abstract:
The present invention relates to a method for preventing, improving or treating fatty liver by administering an effective amount of azelaic acid to a subject. Azelaic acid is a compound primarily contained in a natural product, has no or fewer side effects and an effect of reducing the degree of accumulation of triglycerides in liver tissue, and thus may be used in treatment and improvement of non-alcoholic fatty liver. In addition, due to an anti-inflammatory effect, azelaic acid may be used in the treatment of steatohepatitis. Therefore, the azelaic acid according to the present invention is expected to be effectively used in food material, drug composition and a health functional food to treat fatty liver or steatohepatitis.

Claim (Index 2):
The method according to  claim 1 , wherein the method enables the activation of olfactory receptor 544 (Olfr544) in liver tissue.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 99.0
- Lexical Diversity: 1.85507
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15503611', '12758523', '15858444', '14968183', '12790575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7180887609583457
- 35 USC 102 Novelty (BERT): 0.5157878280885619
- Combined Prediction Score: 0.6978586676713674
- Mean Citation Score: 188.85832
- Max Citation Score: 199.20642
- Similarity Product: 103.32812142973066

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test